Aminosalicylic Acids

A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.
DrugDrug NameDrug Indication
DB00233Aminosalicylic AcidFor the treatment of tuberculosis
DB00244MesalazineMesalazine is indicated for the induction of remission in patients with active or mild to moderate acute exacerbations of ulcerative colitis and for the maintenance of remission of ulcerative colitis [FDA Label], [L5101]. Prescribing information for mesalazine in the UK also indicates the medication for the maintenance of remission of Crohn's ileo-colitis [L5101].
DB01014BalsalazideFor the treatment of mildly to moderately active ulcerative colitis.